{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:50:41Z","timestamp":1793843441064,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007224","name":"Connaught Fund","doi-asserted-by":"publisher","award":["514681"],"award-info":[{"award-number":["514681"]}],"id":[{"id":"10.13039\/501100007224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000098","name":"Stem Cell Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["CRC-2022-00575"],"award-info":[{"award-number":["CRC-2022-00575"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJH-185722"],"award-info":[{"award-number":["PJH-185722"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-195669"],"award-info":[{"award-number":["PJT-195669"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-190109"],"award-info":[{"award-number":["PJT-190109"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-192011"],"award-info":[{"award-number":["PJT-192011"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2023-05124"],"award-info":[{"award-number":["RGPIN-2023-05124"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015680","name":"J.P. Bickell Foundation","doi-asserted-by":"publisher","award":["515159"],"award-info":[{"award-number":["515159"]}],"id":[{"id":"10.13039\/100015680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["43711"],"award-info":[{"award-number":["43711"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL174773"],"award-info":[{"award-number":["1R01HL174773"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.mattod.2025.11.032","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T12:16:14Z","timestamp":1764418574000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration"],"prefix":"10.1016","volume":"92","author":[{"given":"Songtao","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5772-3269","authenticated-orcid":false,"given":"Lauren","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6336-0229","authenticated-orcid":false,"given":"Nicholas C.","family":"Solek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-1813","authenticated-orcid":false,"given":"Tyler","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Savguira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Luozhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7671-725X","authenticated-orcid":false,"given":"Yanchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingzhen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-9143","authenticated-orcid":false,"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mattod.2025.11.032_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.mattod.2025.11.032_b0010","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.ymthe.2025.03.034","article-title":"Clinical development of therapeutic mRNA applications","volume":"33","author":"\u017bak","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mattod.2025.11.032_b0015","first-page":"11","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.mattod.2025.11.032_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-021-01348-0","article-title":"mRNA therapeutics in cancer immunotherapy","volume":"20","author":"Beck","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mattod.2025.11.032_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.mattod.2025.11.032_b0030","article-title":"RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments","author":"Savguira","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mattod.2025.11.032_b0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mattod.2025.11.032_b0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ymthe.2018.11.018","article-title":"mRNA-based protein replacement therapy for the heart","volume":"27","author":"Magadum","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mattod.2025.11.032_b0045","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mattod.2025.11.032_b0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mattod.2025.11.032_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24606","article-title":"Lipid nanoparticles: the game-changer in CRISPR-Cas9 genome editing","volume":"10","author":"Mohammadian Farsani","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.mattod.2025.11.032_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.579062","article-title":"Genome Editing for CNS Disorders","volume":"14","author":"Duarte","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mattod.2025.11.032_b0065","doi-asserted-by":"crossref","unstructured":"J. Gao, S. Gunasekar, Z.J. Xia, K. Shalin, C. Jiang, H. Chen, D. Lee, S. Lee, N.D. Pisal, J.N. Luo, A. Griciuc, J.M. Karp, R. Tanzi, N. Joshi, J. Gao, S. Gunasekar, Z.J. Xia, K. Shalin, C. Jiang, H. Chen, D. Lee, S. Lee, N.D. Pisal, J.N. Luo, A. Griciuc, J.M. Karp, R. Tanzi, N. Joshi, Gene therapy for CNS disorders: modalities, delivery and translational challenges, Nature Reviews Neuroscience 2024 25:8-25.","DOI":"10.1038\/s41583-024-00829-7"},{"key":"10.1016\/j.mattod.2025.11.032_b0070","doi-asserted-by":"crossref","unstructured":"J. Sun, S. Roy, J. Sun, S. Roy, Gene-based therapies for neurodegenerative diseases, Nature Neuroscience 2021 24:3-24.","DOI":"10.1038\/s41593-020-00778-1"},{"key":"10.1016\/j.mattod.2025.11.032_b0075","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/nn.3539","article-title":"Deciphering the functions and regulation of brain-enriched A-to-I RNA editing","volume":"16","author":"Li","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mattod.2025.11.032_b0080","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.mattod.2025.11.032_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606944","article-title":"Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to B lymphocytes","volume":"29","author":"Fenton","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mattod.2025.11.032_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122859","article-title":"Synthetic nanomaterials for spleen-specific mRNA delivery","volume":"314","author":"Nie","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.mattod.2025.11.032_b0095","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1039\/D5BM00322A","article-title":"Non-viral mRNA delivery to the lungs","volume":"13","author":"Healy","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mattod.2025.11.032_b0100","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1021\/acs.nanolett.4c01854","article-title":"Lung-specific mRNA delivery enabled by sulfonium lipid nanoparticles","volume":"24","author":"Popoola","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.mattod.2025.11.032_b0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mattod.2025.11.032_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.mattod.2025.11.032_b0115","doi-asserted-by":"crossref","unstructured":"Z. Liu, Y. Zhang, H. Li, K. Guo, M. Tian, D. Cao, D.D. Kang, Y. Xue, X. Hou, C. Wang, S. Wang, Y. Zhong, C. Yu, B. Deng, D.W. McComb, Y. Dong, Furan-Derived Lipid Nanoparticles for Transporting mRNA to the Central Nervous System, Journal of the American Chemical Society, 147.","DOI":"10.1021\/jacs.4c16326"},{"key":"10.1016\/j.mattod.2025.11.032_b0120","doi-asserted-by":"crossref","first-page":"13152","DOI":"10.1021\/acs.jmedchem.1c00910","article-title":"Strategies for structural modification of small molecules to improve blood\u2013brain barrier penetration: a recent perspective","volume":"64","author":"Xiong","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mattod.2025.11.032_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mattod.2025.11.032_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-024-02114-5","article-title":"Blood\u2013brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","author":"Wang","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mattod.2025.11.032_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417097","article-title":"Lipid nanoparticles enhance mRNA delivery to the central nervous system upon intrathecal injection","volume":"37","author":"Xue","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mattod.2025.11.032_b0140","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","article-title":"Evolving drug delivery strategies to overcome the blood brain barrier","volume":"22","author":"Hersh","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mattod.2025.11.032_b0145","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biochem.3c00371","article-title":"Lipid nanoparticles deliver mRNA to the brain after an intracerebral injection","volume":"62","author":"Tuma","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.mattod.2025.11.032_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112599","article-title":"Non-invasive drug delivery across the blood-brain barrier: a prospective analysis","volume":"15","author":"Niazi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mattod.2025.11.032_b0155","doi-asserted-by":"crossref","unstructured":"K.T. Householder, S. Dharmaraj, D.I. Sandberg, R.J. Wechsler-Reya, R.W. Sirianni, K.T. Householder, S. Dharmaraj, D.I. Sandberg, R.J. Wechsler-Reya, R.W. Sirianni, Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice, Scientific Reports 2019 9:1-9.","DOI":"10.1038\/s41598-019-49028-w"},{"key":"10.1016\/j.mattod.2025.11.032_b0160","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cpt.2531","article-title":"Translational approaches for brain delivery of biologics via cerebrospinal fluid","volume":"111","author":"Sadekar","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.mattod.2025.11.032_b0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21037\/atm-20-3814","article-title":"Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications","volume":"9","author":"Capozza","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.mattod.2025.11.032_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060824","article-title":"Improving the brain delivery of chemotherapeutic drugs in childhood brain tumors","volume":"11","author":"Triarico","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mattod.2025.11.032_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2014.05.009","article-title":"Intrathecal delivery of protein therapeutics to the brain: a critical reassessment","volume":"144","author":"Calias","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mattod.2025.11.032_b0180","first-page":"194","article-title":"Nusinersen: a novel antisense oligonucleotide for the treatment of spinal muscular atrophy","volume":"24","author":"Neil","year":"2019","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.mattod.2025.11.032_b0185","article-title":"Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery","volume":"122","author":"Xu","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mattod.2025.11.032_b0190","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mattod.2025.11.032_b0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","article-title":"Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases","volume":"21","author":"Chen","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.mattod.2025.11.032_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mattod.2025.11.032_b0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41551-023-01082-6","article-title":"Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA","volume":"9","author":"Li","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mattod.2025.11.032_b0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","article-title":"Structure and function of cationic and ionizable lipids for nucleic acid delivery","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mattod.2025.11.032_b0215","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mattod.2025.11.032_b0220","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.mattod.2025.11.032_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mattod.2025.11.032_b0230","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/acs.nanolett.0c01386","article-title":"Deconvoluting lipid nanoparticle structure for messenger RNA delivery","volume":"20","author":"Eygeris","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.mattod.2025.11.032_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.137334","article-title":"Facile lipid nanoparticle size engineering approach via controllable fusion induced by depletion forces","volume":"691","author":"Wang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mattod.2025.11.032_b0240","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.mattod.2025.11.032_b0245","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archneurol.2011.167","article-title":"Alzheimer's disease neuroimaging initiative, the dynamics of cortical and hippocampal atrophy in alzheimer disease","volume":"68","author":"Sabuncu","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mattod.2025.11.032_b0250","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jmri.27195","article-title":"Structural and functional thalamic changes in Parkinson's disease with mild cognitive impairment","volume":"52","author":"Li","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.mattod.2025.11.032_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222002","article-title":"Increased functional connectivity of thalamic subdivisions in patients with Parkinson\u2019s disease","volume":"14","author":"Owens-Walton","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.mattod.2025.11.032_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.601","article-title":"Increased thalamic centrality and putamen-thalamic connectivity in patients with parkinsonian resting tremor","volume":"7","author":"Gu","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.mattod.2025.11.032_b0265","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mattod.2025.11.032_b0270","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1021\/acsnano.3c02268","article-title":"Ionizable lipid nanoparticles for therapeutic base editing of congenital brain disease","volume":"17","author":"Palanki","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mattod.2025.11.032_b0275","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ymthe.2023.02.009","article-title":"A luciferase reporter mouse model to optimize invivo gene editing validated by lipid nanoparticle delivery of adenine base editors","volume":"31","author":"Yu","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mattod.2025.11.032_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1172805","article-title":"Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives","volume":"17","author":"Palmieri","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mattod.2025.11.032_b0285","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.mattod.2025.11.032_b0290","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mattod.2025.11.032_b0295","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."}],"container-title":["Materials Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369702125005085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369702125005085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:10:25Z","timestamp":1781323825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369702125005085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":59,"alternative-id":["S1369702125005085"],"URL":"https:\/\/doi.org\/10.1016\/j.mattod.2025.11.032","relation":{},"ISSN":["1369-7021"],"issn-type":[{"value":"1369-7021","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration","name":"articletitle","label":"Article Title"},{"value":"Materials Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mattod.2025.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}